Menu

AACB 2017 - Call for Abstracts

AACB 2017 - Call for Abstracts

CALL FOR ABSTRACTS

The Australasian Association of Clinical Biochemists invite delegates to submit abstracts for presentation at the AACB 55th Annual Scientific Conference.

Abstracts are invited from all areas in and around clinical biochemistry to present as an oral or poster presentation. While the AACB encourages the submission of abstracts from all areas related to clinical biochemistry, we also encourage submissions related to the Conference theme, "Times Sensitive Testing".

KEY DATES:

Call for Abstracts Open Now Open
Call for Abstracts close 2 June 2017
Notification of Acceptance From 10 July 2017
Early bird Registration closes 21 July 2017

ABSTRACT SUBMISSION

All abstracts will be selected according to the following criteria:

  • Originality and interest
  • Structure and clarity
  • Scientific validity
  • Potential significance

General Information

All abstracts must be submitted ONLINE.

The abstract must be submitted as a WORD document (as an attachment). A sample abstract is available to download to assist you in following the required format.

When submitting an abstract you will be asked to setup an account with a password, which you can then use to submit additional abstracts as well as edit draft abstracts until the closing date.

Please note all accepted presenters must register to attend the conference. If you have not registered and paid by 31 July 2017 your paper may be taken out of the program.

Please note Posters must be displayed for the entire three days of the Conference. Poster presenters must be present at their poster on their designated day.

INSTRUCTIONS

  • Abstracts must be typed in English
  • The abstract must be submitted as a WORD document (as an attachment) and must be typed in the required format – please use the Sample Abstract provided.
  • Word Limit: maximum 300 words in the body of the abstract. Abstracts over this limit will be asked to be revised to the word limit.
  • Do not include tables or figures.
  • If you wish to include QAP data in your abstract you must obtain prior written consent from RCPA Quality Assurance Programs. Please send your request to Mr Peter Graham at peter.graham@rcpaqap.com.au.
  • Abstracts will be reproduced as submitted by the author with minimal editing.
  • Abstracts should be thoroughly checked for correct spelling and grammar before finalising the submission.
  • Please ensure that you include all information requested in the online abstract submission form.
  • The organising committee reserves the right to decline unsuitable topics.

Format & Content

Font Type
Times New Roman
Font Size
12 point
Line Spacing
Single
Title
Uppercase and Bold
Left Justify
Please avoid the use of brand/company names in the title.
Author(s)
(leave one line space between authors & title)
Initials then Surname.
Presenting author is bold and underlined.
If more than one author & address insert a superscript number at the end of the surname after a comma (for each author).
Left justify
Author(s) Address
(next line under authors)
Include institution, city, state, postcode and country. (Do not include department names).
If more than one author / address designate each author’s address by a superscripted number before the address.
Left justify
Email address
Insert presenting author’s email address
Left justify
Main Body
300 word limit
Do not include tables or figures.
Abstracts over 300 words in the body or with tables in the abstract will not be accepted. Your abstract will be sent back to you to reduce to the 300 word limit and remove the tables.

The abstract should be an informative document able to stand alone in its content and meaning.

The main body should be presented (where possible) under the following headings:

  • Introduction (the study objectives)
  • Methods (a brief statement of methods used)
  • Results (a summary of results, including statistical significance in text; do not include tables or figures. It is not sufficient to say that results will be discussed)
  • Conclusion (a brief but clear conclusion drawn from the results shown)

The content must not have been previously published.

Use abbreviations with restraint. Terms must be spelt fully the first time they appear.

Fully justify

Abstract Acknowledgement

A confirmation email acknowledging receipt of your abstract submission will be automatically emailed to you once you have completed the online abstract submission. If you do not receive this confirmation email, or wish to make changes to your submitted abstract*, please contact the Conference Secretariat.

If you wish to submit an additional abstract you can log back into the submission form by clicking on the submission link and signing in with your email and password. NOTE: If you wish to edit your abstract only 'saved as draft' abstracts can be edited online until the closing date. *If your fully submitted your abstract and wish to make changes please email sharon@conlog.com.au with the changes.

Please note that all correspondence will be sent to the e-mail address from which the submitted abstract was received.

Authors will be advised whether their abstract/s have been accepted from 10 July 2017.

AUTHORISATION & PUBLICATION OF ABSTRACTS

By submitting this abstract you are consenting to the publication of your abstract, if accepted, in the Conference App or Handbook, and in the Clinical Biochemists Reviews (subject to CBR Editorial team approval).

All submissions must complete the Copyright and Conflict of Interest section in the online submission form, as part of the submission process.

Copyright & Declaration of Interest

Assignment of copyright for Clinical Biochemists Reviews Journal
The Author(s) assign to the Association and its successors all rights, title and interest in the Abstract now or later protected (including by any renewal, extension or reversion of copyright) by Copyright Laws of Australia and New Zealand. If this Abstract is not published within twelve months from the date above, this Assignment is void.

If portions of this Abstract have been previously published, permission has been obtained for publication in the Clinical Biochemist Reviews and the Author(s) are submitting a copy of the permission release and copy for credit lines with this Abstract. The Association can edit, adapt or change this Abstract at its sole discretion.

The Association grants to Authors the royalty-free right to republish the Abstract in any book of which they are the Author or Editor, provided that any republication includes a clear written notice of the Association’s copyright. All rights assigned to the Association shall inure to the benefit of all persons, firms and corporations who acquire from the Association any right to distribute, transmit, exhibit or exploit the product to the Association and such product may be released under any company or trade name, brand, trademark or other designation desired by the Association. This assignment shall be governed by and construed under the laws of the State of Western Australia

Declaration of Interest Definition
A conflict of interest arises when speakers/authors have interests that are not fully apparent and that may influence their judgement in such a way that an independent observer might reasonably question whether the statements made are influenced by their own interests, and or that which, when revealed later, would make a reasonable reader/member of the audience feel misled or deceived. They may be personal, commercial, political, academic or financial. Financial interests may include employment, research funding and stock or share ownership, payment for lectures or travel, consultancies and company support of staff.

Policy of the AACB on Conflict of Interest
All speakers/authors must disclose, on the disclosure of interest form, all relationships that could be viewed as presenting a potential conflict of interest including any affiliation with or financial involvement in, or payments or other assistance in kind from, any organisation with direct interest in the subject matter. The reason for requesting disclosure of possible conflict of interest is not to exclude speakers/authors, but to inform the audience/reader so they may decide for themselves whether or not a presentation/article may be biased.